• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新思考辅助束放射治疗对非典型脑膜瘤患者总生存期的影响:年龄因素

Rethinking the effects of adjuvant beam radiation therapy on overall survival in atypical meningioma patients: age considerations.

作者信息

Li Chao, Qin Jiajun, Xue Fei, Shen Zhaoli, Lin Qi, Xue Yajun, Chen Xianzhen

机构信息

Department of Neurosurgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.

Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Front Neurol. 2024 Mar 15;15:1360741. doi: 10.3389/fneur.2024.1360741. eCollection 2024.

DOI:10.3389/fneur.2024.1360741
PMID:38560728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10978650/
Abstract

BACKGROUND

This study aimed to investigate the effects of adjuvant beam radiation therapy (ABRT) on overall survival (OS) in patients with primary single intracranial atypical meningioma (AM), with a focus on age-related outcomes.

METHODS

We conducted a retrospective study using data from SEER database. Our cohort consisted of patients diagnosed with a primary single intracranial AM tumor and had undergone surgery. The primary endpoint was OS. For survival analysis, univariable and multivariable Cox regression analysis were performed. A multivariable additive Cox model was used to assess the functional relationship between age and OS in patients with or without ABRT.

RESULTS

Of the 2,759 patients included, 1,650 underwent gross total resection and 833 received ABRT. Multivariable Cox analysis indicated that ABRT did not significantly influence OS across the entire cohort. According to the multivariable generalized additive Cox model, the relative risk of all-cause mortality increased with advancing age in both ABRT-yes and ABRT-no group. ABRT-yes had a lower relative risk than ABRT-no when age ≤ 55 years old while a higher relative risk when age > 55 years old. Subsequent multivariable Cox analysis showed that ABRT was associated with a significant lower risk for all-cause mortality in patients with age ≤ 55 years old while a significant higher risk in patients with age > 55 years old.

CONCLUSION

Our study found that ABRT enhanced OS in younger primary single intracranial AM patients. But we also revealed a negative correlation between OS and ABRT in older patients.

摘要

背景

本研究旨在探讨辅助束放射治疗(ABRT)对原发性单发颅内非典型脑膜瘤(AM)患者总生存期(OS)的影响,重点关注与年龄相关的结果。

方法

我们使用监测、流行病学和最终结果(SEER)数据库的数据进行了一项回顾性研究。我们的队列包括被诊断为原发性单发颅内AM肿瘤并接受过手术的患者。主要终点是总生存期。为了进行生存分析,我们进行了单变量和多变量Cox回归分析。使用多变量加法Cox模型评估接受或未接受ABRT的患者年龄与总生存期之间的函数关系。

结果

在纳入的2759例患者中,1650例接受了全切除,833例接受了ABRT。多变量Cox分析表明,ABRT对整个队列的总生存期没有显著影响。根据多变量广义加法Cox模型,在接受ABRT和未接受ABRT的组中,全因死亡率的相对风险均随年龄增长而增加。年龄≤55岁时,接受ABRT组的相对风险低于未接受ABRT组;而年龄>55岁时,接受ABRT组的相对风险更高。随后的多变量Cox分析表明,ABRT与年龄≤55岁患者的全因死亡率显著较低风险相关,而与年龄>55岁患者的显著较高风险相关。

结论

我们的研究发现,ABRT可提高年轻原发性单发颅内AM患者 的总生存期。但我们也揭示了老年患者的总生存期与ABRT之间存在负相关。

相似文献

1
Rethinking the effects of adjuvant beam radiation therapy on overall survival in atypical meningioma patients: age considerations.重新思考辅助束放射治疗对非典型脑膜瘤患者总生存期的影响:年龄因素
Front Neurol. 2024 Mar 15;15:1360741. doi: 10.3389/fneur.2024.1360741. eCollection 2024.
2
Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.确定辅助放疗在脑膜瘤治疗中的作用:一项监测、流行病学和最终结果分析。
Neurosurg Focus. 2019 Jun 1;46(6):E3. doi: 10.3171/2019.3.FOCUS1971.
3
Effectiveness of Postoperative Radiotherapy on Atypical Meningioma Patients: A Population-Based Study.术后放疗对非典型脑膜瘤患者的疗效:一项基于人群的研究。
Front Oncol. 2019 Jan 31;9:34. doi: 10.3389/fonc.2019.00034. eCollection 2019.
4
Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection.高切除率治疗 II 级脑膜瘤患者的设施容量与总生存时间的关系。
World Neurosurg. 2020 Sep;141:e133-e144. doi: 10.1016/j.wneu.2020.05.030. Epub 2020 May 11.
5
Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.辅助放疗与世界卫生组织 II 级脑膜瘤总生存获益相关。
Neuro Oncol. 2017 Sep 1;19(9):1263-1270. doi: 10.1093/neuonc/nox007.
6
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.辅助放疗对非典型性和间变性脑膜瘤的疗效。
Cancer Med. 2019 Jan;8(1):13-20. doi: 10.1002/cam4.1531.
7
Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases.65岁以上乳腺癌脑转移女性的立体定向放射外科治疗
Cancers (Basel). 2023 Dec 27;16(1):137. doi: 10.3390/cancers16010137.
8
Survival Benefit of Adjuvant Radiotherapy in Elderly Patients with WHO Grade III Meningioma.辅助放疗对 WHO 分级为 III 级脑膜瘤老年患者的生存获益。
World Neurosurg. 2019 Nov;131:e303-e311. doi: 10.1016/j.wneu.2019.07.140. Epub 2019 Jul 26.
9
Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis.辅助性外照射放疗能否改善非良性脑膜瘤的预后?一项基于监测、流行病学和最终结果(SEER)的分析。
J Neurosurg. 2012 Oct;117(4):669-75. doi: 10.3171/2012.7.JNS111439. Epub 2012 Aug 17.
10
Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection.初次大体全切除后非典型脑膜瘤复发和生存的术前及组织学预测因素。
World Neurosurg. 2019 Aug;128:e148-e156. doi: 10.1016/j.wneu.2019.04.069. Epub 2019 Apr 14.

本文引用的文献

1
Survival of gastric cancer in China from 2000 to 2022: A nationwide systematic review of hospital-based studies.中国 2000 年至 2022 年胃癌患者的生存状况:一项基于医院的全国性系统综述。
J Glob Health. 2022 Dec 17;12:11014. doi: 10.7189/jogh.12.11014.
2
Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes.脊索样脑膜瘤的长期预后优于其他 WHO 分级 2 型脑膜瘤亚型。
Neurosurgery. 2023 Apr 1;92(4):745-755. doi: 10.1227/neu.0000000000002272. Epub 2022 Dec 8.
3
Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype.
按组织学亚型划分的宫颈癌发病率、生存率和死亡率的种族和民族差异。
J Clin Oncol. 2023 Feb 10;41(5):1059-1068. doi: 10.1200/JCO.22.01424. Epub 2022 Dec 1.
4
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019.美国 2015-2019 年确诊的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2022 Oct 5;24(Suppl 5):v1-v95. doi: 10.1093/neuonc/noac202.
5
Survival Outcomes and Prognostic Factors in Glioblastoma.胶质母细胞瘤的生存结果与预后因素
Cancers (Basel). 2022 Jun 28;14(13):3161. doi: 10.3390/cancers14133161.
6
Survival and Recurrence Outcomes Following Adjuvant Radiotherapy for Grade 2 Intracranial Meningiomas: 13-Year Experience in a Tertiary-Care Center.辅助放疗治疗 2 级颅内脑膜瘤的生存和复发结果:三级医疗中心 13 年经验。
World Neurosurg. 2022 May;161:e748-e756. doi: 10.1016/j.wneu.2022.02.088. Epub 2022 Feb 28.
7
Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study.非典型脑膜瘤患者的术后辅助放疗:一项荟萃分析研究
Front Oncol. 2021 Dec 2;11:787962. doi: 10.3389/fonc.2021.787962. eCollection 2021.
8
Effects of postmastectomy radiotherapy on survival in different age groups for patients with T3N0M0 breast cancer.保乳术后放疗对T3N0M0期乳腺癌患者不同年龄组生存率的影响。
Breast. 2021 Dec;60:247-254. doi: 10.1016/j.breast.2021.11.006. Epub 2021 Nov 16.
9
Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.美国非小细胞肺癌患者的发病率、患病率、生存率和初始治疗的更新。
JAMA Oncol. 2021 Dec 1;7(12):1824-1832. doi: 10.1001/jamaoncol.2021.4932.
10
The Survival Effect of Radiotherapy on Stage II/III Rectal Cancer in Different Age Groups: Formulating Radiotherapy Decision-Making Based on Age.不同年龄组II/III期直肠癌放疗的生存效果:基于年龄制定放疗决策
Front Oncol. 2021 Jul 28;11:695640. doi: 10.3389/fonc.2021.695640. eCollection 2021.